POP Biotechnologies, Inc.
PrivateLast Round
Grant
Jun 3, 2026
Total Funding Raised
$10.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
POP Biotechnologies, Inc. operates in Healthcare & Life Sciences and is based in Buffalo, New York. Its latest recorded funding round was a Grant round in October 2025.
POP Biotechnologies, Inc. is a biotechnology company that develops novel therapeutics and vaccines based on its proprietary porphyrin-phospholipid (PoP) liposome technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
POP Biotechnologies, Inc. Comparables
Compare POP Biotechnologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phoreus Biotechnology, Inc. | 87% | |
| Optimeos Life Sciences | 87% | |
| nCage Therapeutics | 82% |
For institutional investors. Book with your work email.
POP Biotechnologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 3, 2026 | ||||
| Grant | Oct 1, 2025 | ||||
| Grant | Jul 24, 2025 | ||||
| Grant | Nov 26, 2024 | ||||
| Grant | Oct 28, 2019 | ||||
Seed | Oct 7, 2015 |
For institutional investors. Book with your work email.
POP Biotechnologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| CEPI | Grant |
| NIH RADx | Grant |
| Z80 Labs | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 40% MoM.
- May 19, 2026
Monthly visitors increased 161% MoM, reaching 3.3K.
For institutional investors. Book with your work email.
POP Biotechnologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about POP Biotechnologies, Inc.'s valuation, stock price, and market status.
Is POP Biotechnologies, Inc. a public or private company?
POP Biotechnologies, Inc. is a private company.
What is the current stock price of POP Biotechnologies, Inc.?
POP Biotechnologies, Inc. is a private company, so its shares have no public market price. Caplight tracks POP Biotechnologies, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is POP Biotechnologies, Inc. worth (valuation)?
Valuation information for POP Biotechnologies, Inc. is not publicly available.
Can I buy POP Biotechnologies, Inc. stock?
POP Biotechnologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was POP Biotechnologies, Inc.'s last funding round?
POP Biotechnologies, Inc.'s most recent funding round was Grant on June 3, 2026.
Who are the main investors in POP Biotechnologies, Inc.?
Key investors in POP Biotechnologies, Inc. include National Institute of Allergy and Infectious Diseases, CEPI, NIH RADx, National Institutes of Health (NIH).
Will POP Biotechnologies, Inc. IPO soon?
No public IPO plans have been announced for POP Biotechnologies, Inc..
How can I track POP Biotechnologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in POP Biotechnologies, Inc.'s shares on secondary markets.